tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Psychedelic: Clearmind reports results from first cohort in AUD trial
PremiumThe FlyPsychedelic: Clearmind reports results from first cohort in AUD trial
8d ago
VTI ETF Daily Report—11/20/2025
Premium
Market News
VTI ETF Daily Report—11/20/2025
8d ago
NRX Pharmaceuticals: Advancing Towards Revenue Generation and FDA Approval with Strategic Developments
Premium
Ratings
NRX Pharmaceuticals: Advancing Towards Revenue Generation and FDA Approval with Strategic Developments
8d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs 
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs 
11d ago
NRx Pharmaceuticals sees cash runway through 2Q26
Premium
The Fly
NRx Pharmaceuticals sees cash runway through 2Q26
11d ago
NRx Pharmaceuticals reports Q3 EPS (27c) vs. (15c) last year
Premium
The Fly
NRx Pharmaceuticals reports Q3 EPS (27c) vs. (15c) last year
11d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot — 11/13/25
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot — 11/13/25
15d ago
Daily VTI ETF Snapshot: Insights for Investors—11/12/2025
Premium
Market News
Daily VTI ETF Snapshot: Insights for Investors—11/12/2025
16d ago
Daily VTI ETF Snapshot: Insights for Investors – 11/11/2025
Premium
Market News
Daily VTI ETF Snapshot: Insights for Investors – 11/11/2025
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100